Build your first fully functional, Java-based AI agent using familiar Spring conventions and built-in tools from Spring AI.
23h
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
SHELTON, CT / ACCESS Newswire / April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results